Press Release – Parker Waichman LLP is Reviewing Gadolinium Deposition Disease Cases
Parker Waichman LLP is Investigating Gadolinium Deposition Disease Claims Following New, Important FDA Drug Warnings for All Gadolinium-Based Contrast Agents Parker Waichman LLP is reviewing cases of Gadolinium Deposition Disease and gadolinium toxicity caused by Gadolinium-Based Contrast Agents (GBCAs) that are injected during an … [Read more...] about Press Release – Parker Waichman LLP is Reviewing Gadolinium Deposition Disease Cases
Gadolinium Side Effects Could Result In Kidney Failure Lawsuits
Gadolinium Side Effects Recent News. Parker Waichman LLP Files Suit Against Bayer-Schering on Behalf of Woman Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Magnevist. Drug Safety Update Volume 1 Issue 1 August 2007.pdf EMEA Report.pdf FDA Gadolinium Warning 5/23/07 In May 2007, the FDA requested … [Read more...] about Gadolinium Side Effects Could Result In Kidney Failure Lawsuits
FDA Investigating Potential Health Risks of Brain Deposits of Gadolinium-Based MRI Contrast Agents
Recent studies have shown that gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging (MRI) deposit in the brain of some patients who have repeated scans. The Food and Drug Administration (FDA) is investigating possible health risks of such deposits. Recent publications in the medical literature—including an … [Read more...] about FDA Investigating Potential Health Risks of Brain Deposits of Gadolinium-Based MRI Contrast Agents
Dialysis, Kidney Transplant Patients Risk of NSF
NSF Develops In People Who Are Exposed To The Gadolinium Agents. A study of patients exposed to gadolinium contrast dyes at the Mayo Clinic has revealed that hemodialysis patients had a 77-fold higher risk of developing nephrogenic systemic fibrosis (NSF), while kidney transplant patients had a 69-fold higher risk of the disease. … [Read more...] about Dialysis, Kidney Transplant Patients Risk of NSF
Bayer Magnevist Gadolinium Contrast Dye Lawsuits Settlement
Bayer AG has settled some lawsuits involving its gadolinium contrast dye, Magnevist. Plaintiffs in the lawsuits claimed that Magnevist had caused Nephrogenic Systemic Fibrosis (NSF), a potentially fatal condition that develops in people with pre-existing kidney disease. Gadolinium contrast dyes like Magnevist are approved for use … [Read more...] about Bayer Magnevist Gadolinium Contrast Dye Lawsuits Settlement
Gadolinium Contrast Dye Lawsuit Trials
Gadolinium Contrast Dye Lawsuit. The first civil trials involving gadolinium MRI contrast dyes are scheduled to begin early next year. Hundreds of lawsuits have been filed against the makers of gadolinium MRI contrast dyes by people who claim the agents caused them or a loved one to develop Nephrogenic Systemic Fibrosis … [Read more...] about Gadolinium Contrast Dye Lawsuit Trials
Hemodialysis After MRI with Gadolinium May Prevent NSF in Some Kidney Patients
Patients Who Undergo Hemodialysis Following Exposure to Gadolinium During an MRI May Be At Less Risk. A new study indicates that some kidney patients who undergo hemodialysis following exposure to gadolinium contrast dyes during an MRI may be at less risk of developing nephrogenic systemic fibrosis (NSF). The study, conducted by … [Read more...] about Hemodialysis After MRI with Gadolinium May Prevent NSF in Some Kidney Patients
Kidney Patients Risk of Gadolinium MRI NSF Injuries
Gadolinium MRI Procedures Have The Risk Of Developing NSF. Kidney patients need to know that MRI procedures that involve the use of gadolinium contrast dyes could put them at risk of developing Nephrogenic Systemic Fibrosis (NSF). Unfortunately, there are no alternatives for gadolinium contrast dyes available at this time, … [Read more...] about Kidney Patients Risk of Gadolinium MRI NSF Injuries
Gadolinium MRI Contrast Dye Link to NSF
Gadolinium MRI Contrast Dye Link to NSF. NSF (Nephrogenic Systemic Fibrosis), sometimes called NFD (Nephrogenic Fibrosing Dermopathy) is a rare disease that so far has affected only people with pre-existing kidney problems. In 2006, researchers discovered a direct association between NSF and the use of Gadolinium MRI … [Read more...] about Gadolinium MRI Contrast Dye Link to NSF
MRI Contrast Agents Put Kidney Patients at Risk
MRI Contrast Agents have been Implicated in NSF/NSD. Gadolinium based MRI contrast agents have been implicated in at least 1,000 cases of a debilitating disorder called Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NSD) around the world. This horrible disease causes a buildup of collagen in … [Read more...] about MRI Contrast Agents Put Kidney Patients at Risk
Gadolinium MRI Contrast Agents Linked to NSF
Gadolinium MRI Contrast Agents Injury Lawsuits. Gadolinium based MRI contrast agents and Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NFD) have been linked in yet another study. This time, researchers in Scotland have confirmed that gadolinium based contrast agents used in MRI’s are strongly associated with … [Read more...] about Gadolinium MRI Contrast Agents Linked to NSF
NSF / NFD Associated with Gadolinium Based Contrast Agents
Gadolinium Based Contrast Agents Linked To NSF. Nephrogenic Systemic Fibrosis / Nephrogenic Fibrosing Dermopathy (NSF/NFD), a painful conditions that has been linked to the use of gadolinium based contrast agents used in Magnetic Resonance Imaging (MRI), could be more prevalent than once thought. A recently released study also found … [Read more...] about NSF / NFD Associated with Gadolinium Based Contrast Agents
Gadolinium Contrast Used in MRI / MRA Can Cause NSF & NFD
Gadolinium Contrast Can Have A Toxic Effect. Gadolinium contrast agents have long been used in Magnetic Resonance Imagining (MRI) to enhance the quality of images. But in some patients, Gadolinium can have a toxic affect, causing a condition known of Nephrogenic Systemic Fibrosis (NSF) Gadolinium contrast agents are injected into … [Read more...] about Gadolinium Contrast Used in MRI / MRA Can Cause NSF & NFD
